Institute of Medicine large for gestational age pregnancy outcomes small for gestational age weight gain a b s t r a c t Objective: To investigate perinatal outcomes according to the 2009 Institute of Medicine (IOM) gestational weight gain (GWG) guidelines. Materials and methods: A retrospective cohort study was conducted among all term, singleton, live births to women who delivered at the Taipei Chang Gung Memorial Hospital, Taipei, Taiwan between 2009 and 2014. Women were categorized into three groups based on prepregnancy body mass index and GWG relative to the IOM guidelines. Multivariable logistic regression analysis was used to assess the associations between GWG outside the IOM guidelines and adverse perinatal outcomes. Women with GWG within the guidelines served as the reference group. Results: Of 9301 pregnancies, 2574 (27.7%), 4189 (45.0%), and 2538 (27.3%) women had GWG below, within, and above the IOM guidelines. Women with GWG above the IOM guidelines were at risk for preeclampsia [adjusted odds ratio (OR) 3.0, 95% confidence interval (CI) 1.9e4.7], primary cesarean delivery (adjusted OR 1.4, 95% CI 1.2e1.6) due to dysfunctional labor and cephalopelvic disproportion, large-for-gestational age (adjusted OR 1.8, 95% CI 1.5e2.1), and macrosomic neonates (adjusted OR 2.2, 95% CI 1.6e3.1). Women with GWG below the IOM guidelines were more likely to be diagnosed with gestational diabetes mellitus (adjusted OR 1.5, 95% CI 1.3e1.8) and were at higher risk for placental abruption (adjusted OR 1.7, 95% CI 1.1e2.5), small-for-gestational age (adjusted OR 1.6, 95% CI 1.4e1.9), and low birth weight neonates (adjusted OR 1.9, 95% CI 1.4e2.4). Conclusion: Women with GWG outside the 2009 IOM guidelines were at risk for adverse maternal and neonatal outcomes.
Introduction
In 2009, the Institute of Medicine (IOM) published revised guidelines for weight gain during pregnancy [1] . Key changes made from the previous 1990 IOM recommendations include: (1) the adoption of the body mass index (BMI) categories developed by the International Obesity Task Force and endorsed by the World Health Organization, thus providing a consistent and universal message to both women and health care providers about weight status; (2) a change in the cut-off points for the prepregnancy BMI category, resulting in a smaller proportion of women classified as underweight and a larger proportion classified as overweight; and (3) a specific and relatively narrow range of weight gain recommended for obese women instead of a lower limit. The recommendation is for underweight, normal weight, overweight, and obese women to gain 12.5e18 kg,11.5e16 kg, 7e11.5 kg, and 5e9 kg, respectively. The 2009 IOM weight gain guidelines were subsequently endorsed by the Ministry of Health and Welfare, Taiwan, and are incorporated into the Maternal Health Booklet for every pregnant woman in Taiwan.
Nevertheless, there have been only a few studies examining maternal and neonatal outcomes in relation to the 2009 IOM guidelines [2e11] . Most of these studies were performed on the American or European populations [2,6e11] and have mainly focused on the association between weight gain and neonatal birth weight [4e8] . Data on whether adherence to the guidelines is associated with improved maternal and neonatal outcomes in Taiwanese women remain scarce. Therefore, we conducted a retrospective cohort study to investigate the associations between adverse perinatal outcomes and gestational weight gain (GWG) above or below the 2009 IOM guidelines.
Materials and methods
A retrospective cohort study was conducted among all term, singleton, live births to women who delivered at the Taipei Chang Gung Memorial Hospital, Taipei, Taiwan between 2009 and 2014. The study data were obtained from a computerized obstetrics database, which included demographic characteristics, medical and obstetric histories, and information regarding the course of the index pregnancy and perinatal outcomes. The data in this database were collected by trained personnel through daily abstraction from the medical and delivery records and via postpartum interviews, if necessary, to collect supplemental information. Audits of these data were routinely performed every 2 weeks at the departmental meetings. The study was approved by the Institutional Review Board of Chang Gung Memorial Hospital.
We analyzed all deliveries after 37 0/7 weeks of gestation (n ¼ 9972), excluding pregnancies complicated by multiple gestations (n ¼ 466), fetal chromosomal or structural anomalies (n ¼ 101), and fetal demise (n ¼ 46). Women with chronic hypertension (n ¼ 28) and prepregnancy diabetes mellitus (n ¼ 30) were also excluded. Overall, a total of 9301 deliveries were selected for the present analysis. Figure 1 depicts the sample selection process.
In this hospital, all pregnant women were measured for the height and self-reported prepregnancy weight was recorded at their first antenatal visit. Height and self-reported prepregnancy weight were used to calculate the prepregnancy BMI [calculated as weight (kg)/height (m) 2 ], which was further categorized into four groups: underweight (<18.5 kg/m 2 ), normal weight (18.5e24.9 kg/ m 2 ), overweight (25.0e29.9 kg/m 2 ), and obese (30.0 kg/m 2 ).
GWG was calculated by subtracting each individual woman's prepregnancy weight from her weight at delivery. Women were categorized into three groups based on prepregnancy BMI and GWG relative to the IOM guidelines: (1) weight gain below, (2) weight within, and (3) weight gain above the IOM guidelines.
Perinatal outcomes were compared between the three groups of women, using GWG within the IOM guidelines as the reference group. We examined the following maternal outcomes: gestational diabetes mellitus (GDM), preeclampsia, premature rupture of membranes, acute chorioamnionitis, induction of labor, placental abruption, placenta accreta, postpartum hemorrhage (>500 mL for vaginal delivery and >1000 mL for cesarean delivery), operative vaginal delivery, severe perineal injury (3 rd and 4 th degree perineal injury), and primary cesarean delivery (defined as a cesarean delivery performed for the first time on a pregnant woman). Neonatal outcomes examined were low birth weight (<2500 g), small-for-gestational age (SGA, defined as a birth weight below the 10 th percentile for the mean weight corrected for fetal sex and gestational age), large-for-gestational age (LGA, defined as a birth weight above the 90 th percentile for the mean weight corrected for fetal sex and gestational age), macrosomia (>4000 g), 1-minute and 5-minute Apgar score < 7, and neonatal intensive care unit admission. Statistical analyses were performed using SPSS software, version 20.0 (SPSS Inc., Armonk, NY, USA). The categorical variables were calculated as n (%) and were compared between the groups using the c 2 test. A p value < 0.05 was considered to be statistically significant. Multivariable logistic regression analysis was used to control for potential confounding when assessing the associations between adverse perinatal outcomes and GWG above or below the IOM guidelines. Adjusted odds ratios (OR) and 95% confidence intervals (CI) were calculated to describe the relative risk.
Results
Of the 9301 women analyzed in this study, 1312 (14.1%) were underweight, 6995 (72.0%) were of normal weight, 828 (8.9%) were overweight, and 166 (1.8%) were obese based on their prepregnancy BMI category. Of these women, 2574 (27.7%) women had GWG below, 4189 (45.0%) within, and 2538 (27.3%) above the IOM guidelines. As for the relationship between each prepregnancy BMI category and GWG according to the IOM guidelines (Table 1) , approximately 44% of women of underweight had weight gain below the IOM guidelines. By contrast, more than half of the overweight or obese women had weight gain in excess of the IOM guidelines. Table 2 shows the maternal and pregnancy characteristics associated with GWG relative to IOM guidelines. Women older than 34 years at delivery, of underweight, and having genetic amniocentesis were more likely to gain weight below the IOM guidelines. By contrast, characteristics associated with GWG above the IOM guidelines included maternal age of 20e34 years, overweight or obese, primiparity, and having induction of labor. Table 3 summarizes the association between adverse maternal outcomes and GWG according to IOM guidelines. Compared to women with GWG in concordance with the IOM guidelines, the women who gained less than the IOM guidelines were more likely to be diagnosed with GDM (adjusted OR 1.5, 95% CI 1.3e1.8) and had increased risk for placental abruption (adjusted OR 1.7, 95% CI 1.1e2.5). By contrast, women who had GWG above IOM guidelines were at risk for preeclampsia (adjusted OR 3.0, 95% CI 1.9e4.7) and primary cesarean delivery (adjusted OR 1.4, 95% CI 1.2e1.6) due to dysfunctional labor (adjusted OR 1.3, 95% CI 1.1e1.5) and cephalopelvic disproportion (adjusted OR 1.6, 95% CI 1.2e2.2).
The associations between adverse neonatal outcomes and GWG relative to the IOM guidelines are shown in Table 4 . Women with GWG below the IOM guidelines were more likely to have low birth weight (adjusted OR 1.9, 95% CI 1.4e2.4) or SGA neonates (adjusted OR 1.6, 95% CI 1.4e1.9) compared to the women with GWG within the IOM guidelines. By contrast, the risk for a LGA fetus or macrosomia increased two fold in the women who gained more than the IOM guidelines compared to the women who had weight gain within the IOM guidelines. 
Discussion
Consistent with most prior studies [2e8,10,11], we found significant associations between excessive GWG and increased birth weight (macrosomia) and fetal growth (LGA) and between inadequate GWG and decreased birth weight (low birth weight) and fetal growth (SGA) with respect to the 2009 IOM guidelines. These results underscore the importance of adherence to the weight gain recommendations to optimize neonatal outcomes.
Our previous study showed that a high prepregnancy BMI is associated with the development of preeclampsia [12] . Here, we further demonstrated that women with GWG above the 2009 IOM guidelines had a three-fold increased risk for preeclampsia compared to the women who had GWG within the guidelines, even adjusting for the confounding effects of prepregnancy BMI category. This finding is consistent with most previous studies regarding excessive GWG and the risk for preeclampsia [2,3,9e11] . Although the exact etiology of preeclampsia remains unclear, there is mounting evidence that preeclampsia can manifest as a result of generalized maternal endothelial activation, increased inflammatory state, and metabolic disorders [13, 14] . It is possible that excessive GWG causes alterations in lipid concentrations and oxidative stress, subsequently leading to increased maternal inflammatory response and endothelial activation [15, 16] . Indeed, a recent meta-analysis found strong evidence that hyperglyceridemia is associated with and precedes the onset of preeclampsia [17] . Nevertheless, in a review of a total of 13 studies on dietary intervention to prevent excessive weight gain during pregnancy, Tanentsapf et al [18] found that dietary intervention significantly reduced total GWG, weight retention at 6 months postpartum, and the risk of cesarean delivery, but had no effect on the incidence of preeclampsia. Alternatively, the excessive GWG in women with preeclampsia may be caused by increased fluid retention within the third space, a feature of preeclampsia that is commonly seen in the third trimester. Further studies are needed to clarify the causal relationship between excessive GWG and preeclampsia.
Similar to previous reports [2e4, 10, 11] , we found that women with GWG above the IOM guidelines were more likely to have cesarean delivery. We further demonstrated that this increased risk of cesarean delivery was probably related to increased odds for dysfunctional labor and cephalopelvic disproportion. Both conditions are closely related to increased fetal size (LGA and macrosomia), which is also more common in women with GWG above the IOM guidelines. In addition to preeclampsia, a high prepregnancy BMI is a wellrecognized risk factor for GDM [19] and several previous studies have shown that women with excessive GWG are at increased risk for GDM. However, in this study, we found that women with GWG below the IOM guidelines had a higher rate of GDM than the women with GWG within the guidelines. The explanations for this discrepancy are not clear. It is possible that less total weight gain during pregnancy in women with GDM was due to the result of treatment of GDM, including nutritional therapy, modification of life style, regular monitoring of blood sugar levels, and insulin treatment [20] . Indeed, women who were later diagnosed with GDM were reported to have greater GWG before undergoing the screening test at 24 weeks of gestation compared to the women without GDM [21, 22] .
Our previous study showed that women with a low prepregnancy BMI were at increased risk for placental abruption [23] . In the present study, we further demonstrated that women with GWG below the IOM guidelines also had a higher risk for placental abruption. Similarly, by analyzing more than one million delivery records, Salihu et al [24] found that women whose GWG was less than the IOM recommendations had a 67% increased likelihood of placental abruption, while those who gained more than the recommended amount of weight had a 30% reduced risk for placental abruption, compared with the women who gained weight within the IOM recommendations. Several animal experiments and observational studies have suggested the potential role of micronutrients such as zinc, b-carotene, and vitamins in pregnancy complications including placental abruption [25, 26] . Together, these results suggest that maternal nutrition may contribute to the development of placental abruption.
The strength of this study lies in its ability to include both nulliparous and multiparous women and to adjust for as many confounding factors as possible, as well as the use of patient interview and medical record data rather than relying on vital statistics or birth certificate data; thus, the associations between maternal and neonatal outcomes and GWG with respect to the 2009 IOM guidelines could be objectively investigated.
However, several limitations of our study require attention. First, the prepregnancy weight was self-reported, which is subject to recall error and can lead to under-or overestimation of GWG. Second, this study was limited by its observational and retrospective design. There might be unmeasured confounders that were not have accounted for in this study. Third, this study has a limited sample size of some important but rare pregnancy complications, such as birth injury and neonatal death. Finally, although we have examined the associations between excessive or inadequate GWG and adverse perinatal outcomes, we were not able to confirm the causal relationship. Further studies including information regarding the timing of the diagnosis of preeclampsia and GDM relative to weight gain would help clarify these associations.
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